WAMFF
Alaska Silver Corp.
$0.4778
+0.01%
No data for this timeframe.
Vol
SEC Reports5
Recent Activity
Jun 11, 2026
SEC
Alaska Silver Corp. announced a planned CEO succession: Aaron Schutt will become CEO effective October 1, 2026, succeedi
8-K — Impact 3/10
Jun 4, 2026
SEC
Alaska Silver Corp. announced the commencement of its fully-funded 2026 drilling and exploration program at its 100%-own
8-K — Impact 3/10
May 19, 2026
SEC
Alaska Silver Corp. entered into debt settlement agreements to convert C$1,237,962 in deferred management fees owed to i
8-K — Impact 6/10
Analyst Ratings
3Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
8-K
3/10
Alaska Silver Corp. announced a planned CEO succession: Aaron Schutt will become CEO effective October 1, 2026, succeedi
Jun 11, 2026
NEUTRAL
8-K
3/10
Alaska Silver Corp. announced the commencement of its fully-funded 2026 drilling and exploration program at its 100%-own
Jun 4, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
5 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 4 neutral. Avg impact: 3.4/10.
NEUTRAL
8-K
3/10
Alaska Silver Corp. announced a planned CEO succession: Aaron Schutt will become CEO effective Octob
Jun 11, 2026
NEUTRAL
8-K
3/10
Alaska Silver Corp. announced the commencement of its fully-funded 2026 drilling and exploration pro
Jun 4, 2026
MIXED
8-K
6/10
Alaska Silver Corp. entered into debt settlement agreements to convert C$1,237,962 in deferred manag
May 19, 2026
NEUTRAL
8-K
3/10
Alaska Silver Corp. appointed Aaron Schutt, President and CEO of Doyon Limited (a $500M+ revenue Ala
May 14, 2026
NEUTRAL
8-K
2/10
Alaska Silver Corp. filed an 8-K to report the simplification of its capital structure by eliminatin
May 7, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 89% buy across 9 analysts — 3 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 0.0% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 0.0% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 0.0% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 5 | 1 | 0 | 0 | 89% | |
| May 1, 2026 | 3 | 5 | 1 | 0 | 0 | 89% | |
| Apr 1, 2026 | 3 | 5 | 1 | 0 | 0 | 89% | |
| Mar 1, 2026 | 3 | 5 | 1 | 0 | 0 | 89% | |
| Feb 1, 2026 | 3 | 5 | 1 | 0 | 0 | 89% | |
| Jan 1, 2026 | 3 | 5 | 1 | 0 | 0 | 89% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.